FEATURED SYMPOSIUM PRESENTATION

Choosing CAR T with curative intent

Dr Natasha Kekre

Dr Natasha Kekre of The Ottawa Hospital, Ottawa, Ontario, Canada reviews clinical trial data and real-world evidence for CAR T in 2L DLBCL, highlighting the importance of early referral

18-minute watch
Job code: IHQ-UNB-6055 Date of preparation: July 2024
Dr Natasha Kekre presents a symposium
FEATURED SYMPOSIUM PRESENTATION

Choosing CAR T with curative intent

Dr Natasha Kekre

18-minute watch
Dr Natasha Kekre presents a symposium
Job code: IHQ-UNB-6054 Date of preparation: July 2024

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get.

Reporting of side effects 
If you get any side effects, talk to your doctor or nurse. In Great Britain and Northern Ireland, you can also report side effects directly via the Yellow Card Scheme, Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. You can also report side effects and quality complaints to Gilead. For information now how to report a side effect in another country, click here. By reporting side effects, you can help provide more information on the safety of this medicine.